Literature DB >> 10894806

Homocysteine and its disulfide derivatives: a suggested consensus terminology.

S H Mudd1, J D Finkelstein, H Refsum, P M Ueland, M R Malinow, S R Lentz, D W Jacobsen, L Brattström, B Wilcken, D E Wilcken, H J Blom, S P Stabler, R H Allen, J Selhub, I H Rosenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10894806     DOI： 10.1161/01.atv.20.7.1704

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  40 in total

1.  Enhanced susceptibility to arterial thrombosis in a murine model of hyperhomocysteinemia.

Authors:  Sanjana Dayal; Katina M Wilson; Lorie Leo; Erland Arning; Teodoro Bottiglieri; Steven R Lentz
Journal:  Blood       Date:  2006-06-27       Impact factor: 22.113

2.  Genetic linkage of serum homocysteine in Dominican families: the Family Study of Stroke Risk and Carotid Atherosclerosis.

Authors:  David Della-Morte; Ashley Beecham; Tatjana Rundek; Susan Slifer; Bernadette Boden-Albala; Mark S McClendon; Susan H Blanton; Ralph L Sacco
Journal:  Stroke       Date:  2010-05-20       Impact factor: 7.914

Review 3.  Mechanisms of cardiovascular remodeling in hyperhomocysteinemia.

Authors:  Mesia M Steed; Suresh C Tyagi
Journal:  Antioxid Redox Signal       Date:  2011-04-21       Impact factor: 8.401

4.  Paradoxical absence of a prothrombotic phenotype in a mouse model of severe hyperhomocysteinemia.

Authors:  Sanjana Dayal; Anil K Chauhan; Melissa Jensen; Lorie Leo; Cynthia M Lynch; Frank M Faraci; Warren D Kruger; Steven R Lentz
Journal:  Blood       Date:  2011-12-20       Impact factor: 22.113

5.  Gaussian numerical analysis and terahertz spectroscopic measurement of homocysteine.

Authors:  Tian Li; Hongyun Ma; Yan Peng; Xiaohong Chen; Zhi Zhu; Xu Wu; Tianyi Kou; Bin Song; Shiwei Guo; Lizhuang Liu; Yiming Zhu
Journal:  Biomed Opt Express       Date:  2018-10-16       Impact factor: 3.732

6.  Overexpression of dimethylarginine dimethylaminohydrolase protects against cerebral vascular effects of hyperhomocysteinemia.

Authors:  Roman N Rodionov; Hayan Dayoub; Cynthia M Lynch; Katina M Wilson; Jeff W Stevens; Daryl J Murry; Masumi Kimoto; Erland Arning; Teodoro Bottiglieri; John P Cooke; Gary L Baumbach; Frank M Faraci; Steven R Lentz
Journal:  Circ Res       Date:  2009-12-17       Impact factor: 17.367

7.  Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia.

Authors:  Sanjana Dayal; Roman N Rodionov; Erland Arning; Teodoro Bottiglieri; Masumi Kimoto; Daryl J Murry; John P Cooke; Frank M Faraci; Steven R Lentz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-20       Impact factor: 4.733

8.  Trends in clinical laboratory homocysteine testing from 1997 to 2010: the impact of evidence on clinical practice at a single institution.

Authors:  Corinne M Klykov; Steven R Lentz
Journal:  Clin Chem Lab Med       Date:  2013-03-01       Impact factor: 3.694

Review 9.  Classical homocystinuria: vascular risk and its prevention.

Authors:  S Yap
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

10.  Enzyme replacement with PEGylated cystathionine β-synthase ameliorates homocystinuria in murine model.

Authors:  Erez M Bublil; Tomas Majtan; Insun Park; Richard S Carrillo; Helena Hůlková; Jakub Krijt; Viktor Kožich; Jan P Kraus
Journal:  J Clin Invest       Date:  2016-05-16       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.